A novel therapeutic regimen based on the constrained-disorder principles may improve the response to dimethyl fumarate in multiple sclerosis: Findings from an exploratory feasibility open-label clinical trial.
Lehmann H, Hershkowitz Y, Hurvitz N, Agus S, Berg M, Ilan Y, Vaknin-Dembinsky A
